Francis André - Concepedia

Author

Francis André

ORCID

Also Known As

, André, Andre, Francis, André, Francis, F ANDRE, F Andre, F André, F E Andre, F E André, F. André, F. E. ANDRE

121

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Tampere University GlaxoSmithKline (Switzerland)Vilnius University University of Vienna

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	28	1.8K
2	Management	2	2	52
3	Arts	1	1	22
4	Engineering	1	1	30
5	Health Sciences	1	1	40

Francis André

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Hepatitis B epidemiology in Asia, the Middle East and Africa Francis André Vaccine Hepatitis DEpidemiological TrendHepatitis B EpidemiologyViral HepatitisGlobal Health	2000	353
Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine Francis André The American Journal of Medicine VaccinologyVaccinationVaccine SafetyVaccine DevelopmentViral Hepatitis	1989	205
Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic Timo Vesikari, Erika Isolauri, A. Delem, The Journal of Pediatrics VaccinationVaccine SafetyVeterinary VaccineVaccine DevelopmentVaccine Research	1985	169
Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine Francis André Vaccine VaccinationVaccine Safety5-Year Clinical ExperienceVaccine DevelopmentViral Hepatitis	1990	164
Protection of Peruvian Children Against Rotavirus Diarrhea of Specific Serotypes by One, Two, or Three Doses of the RIT 4237 Attenuated Bovine Rotavirus Vaccine Claudio F. Lanata, Robert E. Black, Roberto del Aguila, The Journal of Infectious Diseases	1989	141
Inactivated candidate vaccines for hepatitis A. Francis André, Anne Hepburn, E. D'Hondt PubMed VaccinationCandidate VaccinesVaccine DevelopmentViral HepatitisImmunology	1990	106
Single dose inactivated hepatitis A vaccine: Rationale and clinical assessment of the safety and immunogenicity Pierre Van Damme, Catharina Matheï, S Thoelen, Journal of Medical Virology	1994	102
Interruption of an outbreak of hepatitis A in two villages by vaccination Viktor Prikazský, Vladimír Oleár, A. Cernoch, Journal of Medical Virology	1994	92
Summary of clinical findings on Engerix-B, a genetically engineered yeast derived hepatitis B vaccine. Francis André, Assad Safary PubMed ImmunohematologyBetween February 1984ImmunologyHepatitis BClinical Findings	1987	89
Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers G Wiedermann, F Ambrosch, Herwig Kollaritsch, Vaccine VaccinationVaccine SafetyHealthy Adult VolunteersViral HepatitisImmunology	1990	85

Page 1